http://oralcancernews.org/wp The Oral Cancer Foundation News Archive Tue, 27 Jul 2010 19:28:38 +0000 http://wordpress.org/?v=2.9.2 en hourly 1 http://oralcancernews.org/wp/asco-non-platinum-regimen-works-in-head-neck-cancer/ http://oralcancernews.org/wp/asco-non-platinum-regimen-works-in-head-neck-cancer/#comments Sun, 06 Jun 2010 14:32:19 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=8806 http://oralcancernews.org/wp/asco-non-platinum-regimen-works-in-head-neck-cancer/feed/ 0 http://oralcancernews.org/wp/asco-antibody-improves-head-and-neck-cancer-results/ http://oralcancernews.org/wp/asco-antibody-improves-head-and-neck-cancer-results/#comments Sun, 06 Jun 2010 14:24:13 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=8800 http://oralcancernews.org/wp/asco-antibody-improves-head-and-neck-cancer-results/feed/ 0 http://oralcancernews.org/wp/presence-of-rash-associated-with-improved-survival-in-patients-receiving-adjuvant-erbitux%c2%ae-for-locally-advanced-head-and-neck-cancer/ http://oralcancernews.org/wp/presence-of-rash-associated-with-improved-survival-in-patients-receiving-adjuvant-erbitux%c2%ae-for-locally-advanced-head-and-neck-cancer/#comments Wed, 18 Nov 2009 02:52:02 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=7393 http://oralcancernews.org/wp/presence-of-rash-associated-with-improved-survival-in-patients-receiving-adjuvant-erbitux%c2%ae-for-locally-advanced-head-and-neck-cancer/feed/ 0 http://oralcancernews.org/wp/erbitux-recognized-by-asco-as-a-2009-major-cancer-advance-as-first-scchn-treatment-to-improve-survival-in-30-years/ http://oralcancernews.org/wp/erbitux-recognized-by-asco-as-a-2009-major-cancer-advance-as-first-scchn-treatment-to-improve-survival-in-30-years/#comments Tue, 17 Nov 2009 05:39:55 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=7372 http://oralcancernews.org/wp/erbitux-recognized-by-asco-as-a-2009-major-cancer-advance-as-first-scchn-treatment-to-improve-survival-in-30-years/feed/ 0 http://oralcancernews.org/wp/report-highlights-cancer-advances/ http://oralcancernews.org/wp/report-highlights-cancer-advances/#comments Tue, 10 Nov 2009 15:08:06 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=7295 http://oralcancernews.org/wp/report-highlights-cancer-advances/feed/ 0 http://oralcancernews.org/wp/at-our-throats/ http://oralcancernews.org/wp/at-our-throats/#comments Thu, 15 Oct 2009 20:20:48 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=6982 http://oralcancernews.org/wp/at-our-throats/feed/ 0 http://oralcancernews.org/wp/erbitux%c2%ae-may-improve-treatment-of-squamous-cell-carcinoma-of-the-esophagus/ http://oralcancernews.org/wp/erbitux%c2%ae-may-improve-treatment-of-squamous-cell-carcinoma-of-the-esophagus/#comments Sat, 03 Oct 2009 14:26:31 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=6783 http://oralcancernews.org/wp/erbitux%c2%ae-may-improve-treatment-of-squamous-cell-carcinoma-of-the-esophagus/feed/ 0 http://oralcancernews.org/wp/lilly-erbitux-cancer-drug-not-worth-price-u-s-scientists-say/ http://oralcancernews.org/wp/lilly-erbitux-cancer-drug-not-worth-price-u-s-scientists-say/#comments Sun, 27 Sep 2009 18:35:34 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=6704 http://oralcancernews.org/wp/lilly-erbitux-cancer-drug-not-worth-price-u-s-scientists-say/feed/ 0 http://oralcancernews.org/wp/initial-coin-study-results-presented-at-european-oncology-congress/ http://oralcancernews.org/wp/initial-coin-study-results-presented-at-european-oncology-congress/#comments Thu, 24 Sep 2009 17:35:41 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=6671 http://oralcancernews.org/wp/initial-coin-study-results-presented-at-european-oncology-congress/feed/ 0 http://oralcancernews.org/wp/u-s-scientists-say-lilly-erbitux-cancer-drug-not-worth-price/ http://oralcancernews.org/wp/u-s-scientists-say-lilly-erbitux-cancer-drug-not-worth-price/#comments Tue, 30 Jun 2009 22:48:22 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=6138 http://oralcancernews.org/wp/u-s-scientists-say-lilly-erbitux-cancer-drug-not-worth-price/feed/ 0 http://oralcancernews.org/wp/use-of-erbitux-in-head-and-neck-cancer-rejected-by-nice/ http://oralcancernews.org/wp/use-of-erbitux-in-head-and-neck-cancer-rejected-by-nice/#comments Thu, 25 Jun 2009 23:43:53 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=6098 http://oralcancernews.org/wp/use-of-erbitux-in-head-and-neck-cancer-rejected-by-nice/feed/ 0 http://oralcancernews.org/wp/monoclonal-antibody-drugs-for-cancer-treatment/ http://oralcancernews.org/wp/monoclonal-antibody-drugs-for-cancer-treatment/#comments Sun, 05 Apr 2009 18:28:05 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=3326 http://oralcancernews.org/wp/monoclonal-antibody-drugs-for-cancer-treatment/feed/ 0 http://oralcancernews.org/wp/update-fda-seeks-more-erbitux-data-on-head-and-neck-cancer/ http://oralcancernews.org/wp/update-fda-seeks-more-erbitux-data-on-head-and-neck-cancer/#comments Mon, 02 Mar 2009 19:42:43 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=1203 http://oralcancernews.org/wp/update-fda-seeks-more-erbitux-data-on-head-and-neck-cancer/feed/ 0 http://oralcancernews.org/wp/avastin-erbitux-combo-proves-dangerous/ http://oralcancernews.org/wp/avastin-erbitux-combo-proves-dangerous/#comments Sat, 07 Feb 2009 20:44:11 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=1071 http://oralcancernews.org/wp/avastin-erbitux-combo-proves-dangerous/feed/ 0 http://oralcancernews.org/wp/merck-serono-launches-erbitux-in-1st-line-treatment-of-head-and-neck-cancer-in-europe/ http://oralcancernews.org/wp/merck-serono-launches-erbitux-in-1st-line-treatment-of-head-and-neck-cancer-in-europe/#comments Sat, 24 Jan 2009 15:51:35 +0000 Oral Cancer Foundation News Team http://oralcancernews.org/wp/?p=979 http://oralcancernews.org/wp/merck-serono-launches-erbitux-in-1st-line-treatment-of-head-and-neck-cancer-in-europe/feed/ 0